1 / 8

Comprehensive Analysis of Cephalosporin Market by 2023

A cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include an increase in the incidence of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea.study provides an in-depth analysis of the global cephalosporin market, with current trends and future estimations

sandeeps88
Download Presentation

Comprehensive Analysis of Cephalosporin Market by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 AMarket Cephalosporin Market Global Opportunity Analysis and Industry Forecast, 2018-2025 Global Opportunity Analysis and Industry Forecast, 2017-2023 Global Opportunity Analysis and Industry Forecast, 2017-2023 Pages:240 Tables:158 Chart:40

  2. Cephalosporin Market According to a new report published by Allied Market Research, titled, "Cephalosporin Market by Generation, Type, Route of Drug Administration, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global cephalosporin market was valued at $3,136 million in 2016, and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023. The third-generation cephalosporin segment held around one-third share of the total market in 2016. Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. Access Full Report : https://www.alliedmarketresearch.com/cephalosporin-market?utm_source=PPT&utm_medium=ss

  3. Cephalosporin Market In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains restrain the market growth. Third-generation cephalosporin segment is expected to dominate the market throughout the analysis period, as these have a broader spectrum of activity. Fifth-generation cephalosporin is expected to register highest CAGR of 7.6% during the forecast period. Asia-Pacific is projected to register the highest CAGR of 16.1% during the forecast period, owing to increase in incidence of infectious diseases. In addition, rise in healthcare expenditure is anticipated to offer a lucrative opportunity for the market growth.The major companies profiled in the report include Allergan Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Lupin Limited, Merck & Co., Inc., Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.

  4. Key Findings of the Cephalosporin Market: • Fifth-generation cephalosporin is projected to grow at a CAGR of 15.6% during the forecast period. • Branded cephalosporin segment is expected to register the highest CAGR of 14.4% during the analysis period. • Injectable cephalosporin is accounted for more than two-fifths share of the global cephalosporin market in 2016. • France and Germany collectively contributed for around one-third share of the European cephalosporin market in 2016. • Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific cephalosporin market in 2016. • For Request Sample: https://www.alliedmarketresearch.com/request-sample/3510?utm_source=PPT&utm_medium=ss Cephalosporin Market

  5. Cephalosporin Market

  6. Cephalosporin Market For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2116?utm_source=PPT&utm_medium=ss

  7. Cephalosporin Market • Contact: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • Toll Free (USA/Canada): • +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060 • Fax: +1⟨855⟩550-5975 • help@alliedmarketresearch.com • Web: https://www.alliedmarketresearch.com

  8. Cephalosporin Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/cephalosporin-market Follow Us On

More Related